PA

PACS Group, Inc.

PACSHealthcareNASDAQ

Medical Care Facilities

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$5.29B
+29.3% YoY
Net Income
$191.5M
+243.5% YoY
EBITDA
$368.5M
+97.4% YoY
Free Cash Flow
$378.3M

Scan Results

Daily timeframe
DateIndicatorDetails
Sep 2 RSI OversoldRSI 24.4, below 30, stock may be oversold
Aug 31 RSI OversoldRSI 21.2, below 30, stock may be oversold
About PACS Group, Inc.

Part of the healthcare sector, PACS Group, Inc. (PACS) is listed under Medical Care Facilities. With a market capitalization of $6.73B, it sits in mid-cap territory. It also provides senior care and independent living facilities.

Where PACS stands vs its 150-day and 200-day moving averages

As of the September 2, 2026 close, PACS finished 9.11% above its 150-day moving average ($38.62) and 12.98% above its 200-day moving average ($37.30). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is PACS overbought or oversold?

At the September 2, 2026 close, PACS's RSI(14) was 24.4, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$6.73B
P/E (TTM)24.85
Fwd P/E15.66
EPS$1.71
Beta-0.13
52W Change+275.4%
ROE27.9%
Analysis

PACS Group, Inc. carries $3.40B in total debt against $164.5M in cash reserves — debt is roughly 20.7x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $378.3M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 27.9% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.6% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $2.42B (2022) to $5.29B (2025), reflecting a 118% increase over the period.

The relatively low beta of -0.13 suggests PACS is a less volatile holding compared to the broader index. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for PACS Group, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms